Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY), today announced the presentation of initial open-label extension (OLE) data from the company’s ongoing Phase 3 ARGUS trial investigating EPX-100 ...
The Livingston, New Jersey-based artificial intelligence infrastructure company is offering the notes due in 2031 with a 1.5% to 2% coupon, according to people familiar with the matter. Shares fell as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback